The Naito Conference aims at providing scientists an unparalleled opportunity for stimulating in-depth knowledge exchange on specific research topics under the atmosphere of a retreat environment in Japan. The participants would experience to be immersed in a full-body of sciences on the topics through the conference, leading to establish networks between world-renowned scientists and ambitious generations. The attendees are limited less than 100 scientists, consisting of both invited lecturers and poster presenters nominated by the organizing committee. The participants are requested full attendance throughout the period of the conference (4 days) as a general rule. The Naito Foundation, a non-profit organization for public services, provides all participants full of accommodations and meals for three nights stay at the conference site.

The 51st Naito Conference

Theme: Microbiome in Health and Disease
Date: June 25(Tue)-June 28(Fri), 2024
Venue: CHATERAISE Gateaux Kingdom SAPPORO（Hokkaido）
Poster Application Period: Monday, November 20, - Tuesday, January 9, 2024
Extension: Until 23:59 January 31 (Wednesday), 2024
Poster Application Period has been closed.

Organizing Committee　 *Titles omitted

Plenary Lecturers　 *Titles omitted

Yasmine BELKAID
National Institute of Allergy and Infectious Diseases, NIH, USA
 
Ruth LEY
Max Planck Institute for Biology Tübingen, Germany

 
Invited Lecturers 　 *Titles omitted

David ARTIS
Department of Microbiology and Immunology, Weill Cornell Medicine, USA
 
Emily P. BALSKUS
Harvard University, USA
 
Ami BHATT
Stanford University, USA
 
Eugene B. CHANG
University of Chicago, USA

Hal DRAKESMITH
MRC Weatherall Institute of Molecular Medicine, UK
 
Eran ELINAV
Weizmann Institute of Science, Israel
 
Sidonia FAGARASAN
RIKEN Center for Integrative Medical Sciences, Japan
 
Florent GINHOUX
Gustave Roussy, France
 
Andrew GOODMAN
Yale University School of Medicine, USA
 
Tissa HATA
UC San Diego, USA
 
Nobuhiko KAMADA
Osaka University, Japan
 
Andrew J. MACPHERSON
University Hospital of Bern, Switzerland
 
Keisuke NAGAO
Arthritis and Musculoskeletal and Skin Diseases, NIH, USA
 
Hiroshi OHNO
RIKEN Center for Integrative Medical Sciences, Japan
 
Michael OTTO
National Institute of Allergy and Infectious Diseases, NIH, USA
 
Tiffany SCHARSCHMIDT
University of California, San Francisco, USA
 
R. Balfour SARTOR
University of North Carolina at Chapel Hill, USA
 
Toshiro SATO
Keio University, Japan